Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: Application of a sampling-based approach

Clinical Infectious Diseases

Volumn 62, Issue 7, 2016, Pages 935-944

  Geng, Elvin H ^a   Odeny, Thomas A ^b   Lyamuya, Rita ^c   Nakiwogga Muwanga, Alice ^d   Diero, Lameck ^e   Bwana, Mwebesa ^f   Braitstein, Paula ^e   Somi, Geoffrey ^c   Kambugu, Andrew ^d   Bukusi, Elizabeth ^b   Wenger, Megan ^g   Neilands, Torsten B ^a   Glidden, David V ^g   Wools Kaloustian, Kara ^h   Yiannoutsos, Constantin ^h   Martin, Jeffrey ^a,g  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c Epidemiology Unit   (Tanzania)

^d MAKERERE UNIVERSITY   (Uganda)

^e ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^f MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h INDIANA UNIVERSITY   (United States)

Author keywords

Africa; antiretroviral therapy; loss to follow up; retention

Indexed keywords

EFAVIRENZ; NEVIRAPINE; STAVUDINE; TENOFOVIR DISOPROXIL; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; EAST AFRICAN; FEMALE; FOLLOW UP; HEALTH CARE SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT TRANSPORT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RISK ASSESSMENT; TANZANIA; TREATMENT OUTCOME; UGANDA; AFRICA; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; HIV INFECTIONS;

ADULT; AFRICA, EASTERN; ANTI-HIV AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE;

EID: 84963985207     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1004     Document Type: Article

References (36)

1. Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Available at: http://www.unaids.org/en/media/.unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-.Report-2013-en.pdf. Accessed 1 July 2015.
2. Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis. 2007; 44: 1500-2.
3. Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clin Infect Dis. 2011; 52(suppl 2): S238-46.
4. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007; 44: 1493-9.
5. van Dijk JH, Sutcliffe CG, Munsanje B, Hamangaba F, Thuma PE, Moss WJ. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. BMC Infect Dis. 2009; 9: 169.
6. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010; 14: 778-84.
7. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007; 19: 658-65.
8. Jewkes R, Abrahams N, Mvo Z. Why do nurses abuse patients?. Reflections from South African obstetric services. Soc Sci Med. 1998; 47: 1781-95.
9. Wanyenze RK, Wagner G, Alamo S, et al. Evaluation of the efficiency of patient flow at three HIV clinics in Uganda. AIDS Patient Care STDS. 2010; 24: 441-6.
10. Amanyire G, Wanyenze R, Alamo S, et al. Client and provider perspectives of the efficiency and quality of care in the context of rapid scale-up of antiretroviral therapy. AIDS Patient Care STDS. 2010; 24: 719-27.
11. Zou J, Yamanaka Y, John M, Watt M, Ostermann J, Thielman N. Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes. BMC Public Health. 2009; 9: 75.
12. Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006; 18: 904-10.
13. BrinkhofMW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008; 86: 559-67.
14. Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007; 12: 687-94.
15. Ware NC, Wyatt MA, Geng EH, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 2013; 10: e1001369.
16. Geng EH, Odeny TA, Lyamuya RE, et al. Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort study. Lancet HIV. 2015; 2: e107-16.
17. Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand Stat 1978: 141-50.
18. Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000; 34: 1273-302.
19. Geng EH, Glidden DV, Bangsberg DR, et al A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa. Am J Epidemiol. 2012; 175: 1080-7.
20. Geng EH, Glidden DV, Bwana MB, et al. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One. 2011; 6: e21797.
21. Frangakis CE, Rubin DB. Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring. Biometrics. 2001; 57: 333-42.
22. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008; 300: 506-7.
23. Hernan MA, Hernandez-Diaz S, Robins JM A structural approach to selection bias. Epidemiology. 2004; 15: 615-25.
24. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999; 8: 3-15.
25. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002; 7: 147-77.
26. BrinkhofMW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to followup in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-Analysis. PLoS One. 2009; 4: e5790.
27. Geng EH, Bwana MB, MuyindikeW, et al. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr. 2013; 63: e64-71.
28. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi. Bull World Health Organ. 2007; 85: 550-4.
29. Decroo T, Telfer B, Biot M, et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. J Acquir Immune Defic Syndr. 2011; 56: e39-44.
30. Decroo T, Van Damme W, Kegels G, Remartinez D, Rasschaert F. Are expert patients an untapped resource for ART provision in sub-Saharan Africa?. AIDS Res Treat. 2012; doi: 10.1155/2012/749718.
31. Hickey MD, Salmen CR, Omollo D, et al. Pulling the network together: quasi-experimental trial of a patient-defined support network intervention for promoting engagement in HIV care and medication adherence on Mfangano Island, Kenya. J Acquir Immune Defic Syndr. 2015; 69: e127-34.
32. Rotheram-Borus M-J, Richter L, Van Rooyen H, et al. Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV. Trials. 2011; 12: 1-10.
33. Chang LW, Kagaayi J, Nakigozi G, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010; 5: e10923.
34. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004; 39: 1005-26.
35. Hibbard JH, Stockard J, Tusler M. Hospital performance reports: impact on quality, market share, and reputation. Health Affairs. 2005; 24: 1150-60.
36. Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014; 59: 1471-9.